Risk factors for procedural interventions for retained products, after failed treatment with misoprostol or mifepristone and misoprostol for first trimester pregnancy loss – A retrospective cohort study
Authors:
- 19 May 2025
- journal article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 311, 114067
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Feasibility of Office-Based Operative Hysteroscopy by a Tissue Removal System Without AnesthesiaJournal of Minimally Invasive Gynecology, 2024
- Bleeding pattern after medical management of early pregnancy loss with mifepristone–misoprostol and its prognostic value: a prospective observational cohort studyArchives of Gynecology and Obstetrics, 2021
- Expectant management of retained products of conception following abortion: A retrospective cohort studyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2021
- Postpartum retained products of conception: Is it possible to avoid postpartum curettage?International Journal of Gynecology & Obstetrics, 2021
- Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trialAmerican Journal of Obstetrics and Gynecology, 2020
- Hysteroscopic removal of retained products of conception following first trimester medical abortionGynecology and Minimally Invasive Therapy, 2017
- Intrauterine adhesions after hysteroscopic treatment for retained products of conception: what are the risk factors?Fertility and Sterility, 2015
- Hysteroscopic management of retained products of conception: meta-analysis and literature reviewEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2014
- A randomized prospective study of misoprostol or mifepristone followed by misoprostol when needed for the treatment of women with early pregnancy failureFertility and Sterility, 2006
- Comparative study between single dose 600 μg and repeated dose of oral misoprostol for treatment of incomplete abortionContraception, 2004